DIFF Scale Operation Research, LLC v. MaxLinear, Inc.

CourtDistrict Court, D. Delaware
DecidedMay 7, 2020
Docket1:19-cv-02109
StatusUnknown

This text of DIFF Scale Operation Research, LLC v. MaxLinear, Inc. (DIFF Scale Operation Research, LLC v. MaxLinear, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
DIFF Scale Operation Research, LLC v. MaxLinear, Inc., (D. Del. 2020).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE

DIFF SCALE OPERATION ) RESEARCH, LLC, ) ) Plaintiff, ) ) v. ) Civil Action No. 19-2109-LPS-CJB ) MAXLINEAR, INC., and ) EXAR CORPORATION, ) ) Defendants. )

REPORT AND RECOMMENDATION In this patent infringement action filed by Plaintiff DIFF Scale Operation Research, LLC (“Plaintiff”) against Defendants MaxLinear, Inc. and Exar Corporation (collectively, “Defendants”), pending is Defendants’ motion to dismiss Counts I and II of Plaintiff’s Complaint, filed pursuant to Federal Rule of Civil Procedure 12(b)(6) (the “Motion”). (D.I. 10) For the reasons set out below, the Court recommends that Defendant’s Motion be GRANTED without prejudice. I. BACKGROUND Plaintiff filed its Complaint on November 7, 2019, in which it alleges that Defendants infringe two different patents. (D.I. 1) In Count I of the Complaint, Plaintiff alleges direct, induced and willful infringement of claim 21 of United States Patent No. 7,881,413 (“the '413 patent”) and in Count II of the Complaint, Plaintiff alleges direct, induced and willful infringement of claim 28 of United States Patent No. 6,664,827 (“the '827 patent”). (Id. at ¶¶ 36- 84) Defendants filed the Motion on January 31, 2020, (D.I. 10), which has been referred to the Court for resolution by Chief United States District Judge Leonard P. Stark, (D.I. 6). Briefing on the Motion was completed on February 20, 2020. (D.I. 15) II. STANDARD OF REVIEW The standard of review here is the familiar two-part analysis applicable to motions made pursuant to Rule 12(b)(6). First, the court separates the factual and legal elements of a claim, accepting “all of the complaint’s well-pleaded facts as true, but [disregarding] any legal

conclusions.” Fowler v. UPMC Shadyside, 578 F.3d 203, 210-11 (3d Cir. 2009). Second, the court determines “whether the facts alleged in the complaint are sufficient to show that the plaintiff has a ‘plausible claim for relief.’” Id. at 211 (quoting Ashcroft v. Iqbal, 556 U.S. 662, 679 (2009)). A plausible claim does more than merely allege entitlement to relief; it must also demonstrate the basis for that “entitlement with its facts.” Id. Thus, a claimant’s “obligation to provide the grounds of his entitle[ment] to relief requires more than labels and conclusions, and a formulaic recitation of the elements of a cause of action will not do[.]” Bell Atl. Corp. v. Twombly, 550 U.S. 544, 555 (2007) (internal quotation marks and citations omitted). In assessing the plausibility of a claim, the court must “‘construe the complaint in the light most favorable to the plaintiff, and determine whether, under any reasonable reading of the complaint,

the plaintiff may be entitled to relief.’” Fowler, 578 F.3d at 210 (quoting Phillips v. Cnty. of Allegheny, 515 F.3d 224, 233 (3d Cir. 2008)). III. DISCUSSION The Court begins (and ends) its analysis here by assessing the adequacy of the Complaint’s allegations of direct infringement of the '413 and '827 patents.1 In order to adequately allege direct infringement under the circumstances at issue here,2 Plaintiff needs to have pleaded facts that plausibly indicate that Defendants’ accused products practice each of the limitations asserted in the relevant claims. See Modern Telecom Sys., LLC v. TCL Corp., Civil

Action No. 17-583-LPS-CJB, 2017 WL 6524526, at *2 (D. Del. Dec. 21, 2017); Raindance

1 Defendants also raise separate arguments challenging the adequacy of Plaintiff’s induced and willful infringement allegations for both the '413 and '827 patents. (See D.I. 11 at 9- 12) However, allegations of induced and willful infringement are predicated on the plausible assertion that the defendant has directly infringed the patents-in-suit. See Välinge Innovation AB v. Halstead New England Corp., Civil Action No. 16-1082-LPS-CJB, 2018 WL 2411218, at *13 (D. Del. May 29, 2018); Varian Med. Sys., Inc. v. Elekta AB, Civil Action No. 15-871-LPS, 2016 WL 3748772, at *2-3 (D. Del. July 12, 2016). Below, the Court finds that Plaintiff has failed to plausibly assert allegations of direct infringement. As a result, the Court will be recommending that the relevant claims of induced and willful infringement also be dismissed. It thus need not separately assess Defendants’ arguments as to induced or willful infringement.

2 This is not a situation, like that in Disc Disease Solutions Inc. v. VGH Solutions., Inc., 888 F.3d 1256 (Fed Cir. 2018), where the plaintiff does not need to rely on a narrative articulation of how the accused products plausibly infringe the elements of the claims. See Super Interconnect Techs. LLC v. HP Inc., Civil Action No. 19-0169-CFC, 2019 WL 6895877, at *2 n.3 (D. Del. Dec. 18, 2019). In Disc Disease, the United States Court of Appeals for the Federal Circuit reversed a district court’s dismissal of the plaintiff’s complaint, where the district court had found that the complaint “did not satisfy the Iqbal/Twombly plausibility pleading standard[.]” Disc Disease, 888 F.3d at 1259. Specifically, the Federal Circuit ruled that the plaintiff had provided the defendant “fair notice of infringement of the asserted patents” where: (1) the case involved “a simple technology”; (2) the asserted patents were attached to the complaint; (3) the complaint specifically identified the accused products, and attached photos of the products as exhibits; and (4) the complaint alleged that the accused products “meet each and every element of at least one claim of [the plaintiff’s] patents.” Id. at 1260 (internal quotation marks and citation omitted). The patent claims at issue in Disc Disease were directed to an apparatus and method that were not unduly complex: “an air injectable band with a rigid panel worn around the waist[, that when] inflated [] expands vertically to provide traction to the spine of the user to relieve back pain” and “a method of manufacturing a wrinkled band by adhering an overlapped sheet creating an inner space and adhering a stretched elastic band above and below the inner space.” Id. at 1257-58. Here, in contrast, the patents-in-suit concern subject matter that is much more technologically sophisticated than that in Disc Disease. And here, Plaintiff included no photographs of the accused products. It did list a few features that those products are alleged to have, (D.I. 1 at ¶¶ 41-44, 66-72), but the Court does not understand (and Plaintiff’s briefing unfortunately did not explain) why the presence of those features help render it plausible that the limitations of the claims are met. Techs., Inc. v. 10x Genomics, Inc., Civil Action No. 15-152-RGA, 2016 WL 927143, at *2-3 (D. Del. Mar. 4, 2016). After all, if after reading a complaint, the Court cannot conclude that it is plausible that the accused infringer’s product reads on a limitation of an asserted claim of a patent-in-suit, then it cannot be plausible that the accused infringer actually infringes that patent

claim. Modern Telecom Sys., 2017 WL 6524526, at *2 (citing cases). Count I of the Complaint alleges that Defendants’ accused products3 directly infringe claim 21 of the '413 Patent. (D.I. 1 at ¶¶ 36-52) That claim recites a “machine-readable medium having instructions stored thereon capable of causing a processor to perform a method of generating a timing signal,” with the method comprising certain steps. ('413 patent, col.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Phillips v. County of Allegheny
515 F.3d 224 (Third Circuit, 2008)
Fowler v. UPMC SHADYSIDE
578 F.3d 203 (Third Circuit, 2009)
Disc Disease Solutions Inc. v. Vgh Solutions, Inc.
888 F.3d 1256 (Federal Circuit, 2018)
SIPCO, LLC v. Streetline, Inc.
230 F. Supp. 3d 351 (D. Delaware, 2017)
Sincavage v. Barnhart
171 F. App'x 924 (Third Circuit, 2006)
Henderson v. Carlson
812 F.2d 874 (Third Circuit, 1987)

Cite This Page — Counsel Stack

Bluebook (online)
DIFF Scale Operation Research, LLC v. MaxLinear, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/diff-scale-operation-research-llc-v-maxlinear-inc-ded-2020.